Throughout the last three months, 4 analysts have evaluated EyePoint Pharmaceuticals (NASDAQ:EYPT), offering a diverse set of opinions from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

Analysts have set 12-month price targets for EyePoint Pharmaceuticals, revealing an average target of $23.0, a high estimate of $30.00, and a low estimate of $15.00. A 25.81% drop is evident in the current average compared to the previous average price target of $31.00.

Diving into Analyst Ratings: An In-Depth Exploration

In examining recent analyst actions, we gain insights into...